Medvedev Warns World Is Growing More Dangerous but Says Russia Seeks to Avoid Global Conflict 
Syria Detains Group Over Rocket Attacks on Damascus Military Airport Amid Hezbollah Allegations 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Russian Drone Strike Kills Miners as Ukraine Pushes for Peace Talks Amid Energy Crisis 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
U.S.–Venezuela Relations Show Signs of Thaw as Top Envoy Visits Caracas 
U.S. Government Faces Brief Shutdown as Congress Delays Funding Deal 
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 
Trump’s Iraq Envoy Mark Savaya Ousted Amid U.S.-Iraq Tensions Over Iran Influence 
Trump Orders DHS to Avoid Protests in Democratic Cities Unless Federal Assets Are Threatened 
U.S. President Donald Trump revealed on Saturday that his administration will deliver an important update on autism this Monday, sparking speculation about new health findings. Speaking at a dinner hosted by the conservative American Cornerstone Institute, Trump described it as “one of the most important things that we will do,” but declined to share details.
The Wall Street Journal recently reported that Health Secretary Robert F. Kennedy Jr. is preparing to announce potential risks tied to Tylenol, a popular pain reliever from Kenvue. According to the report, Kennedy may claim that using Tylenol during pregnancy could be linked to autism, a position that contradicts existing medical guidelines which deem the drug safe.
Autism diagnoses in the United States have climbed dramatically in recent decades, fueling ongoing debate. Data from the Centers for Disease Control and Prevention (CDC) shows that autism prevalence among 8-year-olds reached 1 in 36 in 2020 (2.77%), compared with 2.27% in 2018 and just 0.66% in 2000. Kennedy has repeatedly stated that America is facing an “autism epidemic” driven by environmental toxins, though most scientists argue the condition likely stems from a mix of genetics and environmental factors.
In addition to the autism update, Trump teased another policy rollout. He announced that Mehmet Oz, head of the Centers for Medicare and Medicaid Services, will unveil a “most favored nation” drug pricing model. This initiative aims to lower U.S. prescription drug costs by matching the lowest prices paid by other Organisation for Economic Co-operation and Development (OECD) countries. Trump emphasized that tariffs could be used against nations resisting fair pricing, calling Dr. Oz “a smart, tough guy” who could drive the plan forward.
